← Home
The Proof · June 1, 2026 · 1h 42m

The Surgeon Defending Statins, GLP-1s, and Ancel Keys | Dr Terry Simpson

In this episode, bariatric surgeon and science communicator Dr. Terry Simpson joins Simon Hill to tackle health misinformation, GLP-1 drugs, statin controversy, and the legacy of Ancel Keys. Simpson shares his personal journey with familial hypercholesterolemia and a 50-pound weight loss on tirzepatide. The conversation covers how to spot health hucksters, the science behind GLP-1s derived from Gila monster venom, the silencing of food noise by the medication, and a robust defense of statin therapy using ApoB as a superior risk marker. Simpson also defends the Mediterranean diet based on a trial that was stopped early for ethical reasons, and warns against the dangers of unregulated compounded GLP-1s. The episode blends clinical expertise with first-hand experience in the culture wars of nutrition science.

This summary was generated from show notes and public descriptions, not from a full transcript review. Details may contain inaccuracies.

Canon

Dr. Simpson makes the case for statin therapy using his own lipid numbers: an LDL of 190 lowered to the 40s on statins, and an ApoB in the 40s, against a family history of early heart disease.

Highlights

The Biggest Health Lies: Carnivore and Anti-Vax00:01:02
Dr. Simpson identifies the carnivore diet and anti-vaccine movement as today's most dangerous health misinformation.
How to Spot a Health Huckster00:13:25
Dr. Simpson shares his heuristic for distinguishing legitimate health experts from influencers selling certainty.
The GLP-1 Revolution: From Gila Monster Venom to Life-Changing Medication00:19:12
Dr. Simpson traces the origin of GLP-1 drugs to the Gila monster and explains the difference between native and pharmacological GLP-1, and describes how tirzepatide eliminated his food noise.
Ancel Keys Was Right: The Mediterranean Diet Trial That Changed Everything00:32:51
Dr. Simpson defends Ancel Keys and the Mediterranean diet, pointing to a major trial where the cardiovascular benefits were so dramatic that the study was halted early.
The Danger of Compounded GLP-1s and Deregulation
Dr. Simpson cautions against using unregulated compounded GLP-1 drugs and argues for the importance of FDA oversight.
Was this useful?